CONSULTING AGREEMENT THIS CONSULTING AGREEMENT ("Agreement") is entered into as of August 7, 2000 (the "Effective Date"), by and between Michael G. Acton, a resident of the State of Utah (the "Consultant") and Donlar Corporation, an Illinois...Consulting Agreement • August 15th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Illinois
Addendum AStock Option Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Washington
ADDENDUM AND MODIFICATION OF PURCHASE AGREEMENT This agreement ("Addendum") is adopted as a modification and amendment to that certain Purchase Agreement ("Purchase Agreement") executed as of May 27, 1998 by and between CYPRESS SPRINGS LLC, a...Purchase Agreement • August 18th, 1998 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT ("Agreement") is made and entered into as of January __, 2000 (the "Effective Date") by and between Amerifit Nutrition, Inc. ("Seller"), a Delaware corporation with its principal place of business...Asset Purchase Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
AGREEMENTService Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • California
AGREEMENTConsulting Agreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 10.95 LEASE AGREEMENTLease Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
June 14, 2001Consulting Agreement • June 27th, 2001 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
AGREEMENTManagement Services Agreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
LICENSE AGREEMENT This License Agreement (this "Agreement") is made effective as of January 13, 2000 (the "Effective Date") by and between Amerifit Nutrition, Inc., a Delaware corporation with its principal place of business at 166 Highland Park...License Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
WITNESSETH:Non-Competition Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
ARTICLE 1Asset Purchase Agreement • February 22nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 10.98 BIOMUNE SYSTEMS, INC. INVESTOR QUESTIONNAIRE AND SUBSCRIPTION AGREEMENT ALL SUBSCRIBERS FOR SHARES MUST EXECUTE AN INVESTOR QUESTIONNAIRE AND SUBSCRIPTION AGREEMENT. THIS INFORMATION IS NECESSARY FOR THE PURPOSE OF DETERMINING THE...Subscription Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
RECITALS:License Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXTENSION AGREEMENTExtension Agreement • June 13th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
Exhibit 10.3 AGREEMENTEngagement Agreement • June 13th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 15th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Nevada
PURCHASE AGREEMENT PURCHASE AGREEMENT, dated as of May 27, 1998 (the "Agreement"), by and between CYPRESS SPRINGS LLC, a California limited liability company ("Cypress") managed by Ira E. Ritter, an individual residing in California ("Ritter"), and...Purchase Agreement • June 29th, 1998 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • California
AGREEMENTConsulting Agreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
EXHIBIT 2.1 AMENDED AND RESTATED AGREEMENT AND PLAN OF MERGER THIS AGREEMENT AND PLAN OF MERGER (this "Agreement"), dated as of June 7, 2002, is made by and among Donlar Corporation, an Illinois corporation ("Donlar") and Donlar Biosyntrex...Agreement and Plan of Merger • May 20th, 2003 • Donlar Biosyntrex Corp • Biological products, (no disgnostic substances) • Illinois
RESTATED AND AMENDED PURCHASE AGREEMENT RESTATED AND AMENDED PURCHASE AGREEMENT, effective May 27, 1998 (the "Agreement"), by and among CYPRESS SPRINGS LLC, a California limited liability company ("Cypress") managed by Ira E. Ritter, an individual...Purchase Agreement • January 13th, 1999 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • California
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 15th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Nevada
AGREEMENTLicensing Agreement • February 14th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
RECITALS:Stock Purchase Warrant • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
Exhibit 10.135 EMPLOYMENT AGREEMENT This Employment Agreement is made this 1st day of July, 1996, by and between DONLAR CORPORATION, an Illinois corporation (the "Company"), having a principal place of business at Moffett Campus, 6502 South Archer...Employment Agreement • April 17th, 2002 • Donlar Biosyntrex Corp • In vitro & in vivo diagnostic substances • Illinois
EXHIBIT 10.99 ALLIANCE PROTOTYPE 401(K) PLAN STANDARDIZED ADOPTION AGREEMENT This standardized adoption agreement has been prepared to accommodate the needs of most employers desiring to adopt a 401(k) plan in a prototype format. It is an important...401(k) Plan Adoption Agreement • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • New York
Exhibit 10.1 LETTER OF AGREEMENT This is a Letter of Agreement between Biomune Systems, Inc. (the "Company") and Dr. Allan H. Barker ("Consultant") effective as of June 3, 1997. CONSULTING DUTIES Consultant has performed services for the Company which...Consulting Agreement • June 13th, 1997 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
EXHIBIT 10.117 MARKETING AND CONSULTING SERVICES AGREEMENT THIS MARKETING AND CONSULTING AGREEMENT (the "Agreement") is made as of August 14, 1999, effective April 1, 1999, by and between Harrogate Marketing, L.L.C. ("Harrogate") and Biomune Systems,...Marketing and Consulting Services Agreement • January 13th, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
among DONLAR CORPORATION and DONLAR BIOSYNTREX CORPORATIONBridge and Consolidated Term Loan Agreement • April 16th, 2002 • Donlar Biosyntrex Corp • In vitro & in vivo diagnostic substances • New York
Any party may change its address for notice hereunder by notice to the other parties hereto.Consulting Agreement • March 4th, 1998 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
WITNESSETH:Commercial Lease • November 19th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
1 EXHIBIT 10 CAPITAL CONTRIBUTION, ASSIGNMENT AND ASSUMPTION AGREEMENT KNOW ALL MEN BY THESE PRESENTS, that Donlar Corporation ("Donlar") for good and valuable consideration, the receipt of which is hereby acknowledged, and intending to be legally...Capital Contribution, Assignment and Assumption Agreement • January 22nd, 2001 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
Biomune Systems, Inc. Stock Option Grant and Agreement Pursuant to the terms and conditions of the Biomune Systems, Inc. 1999 Stock Option and Incentive Plan (the "Plan"), Biomune Systems, Inc. (the "Company"), hereby grants to the Participant an...Stock Option Grant and Agreement • February 2nd, 2000 • Biomune Systems Inc • In vitro & in vivo diagnostic substances
Employment Agreement ROBERT P. PIETRANGELO SEPTEMBER 7, 2001Employment Agreement • April 17th, 2002 • Donlar Biosyntrex Corp • In vitro & in vivo diagnostic substances
EXHIBIT 10.5 Biomune Systems, Inc. INCENTIVE STOCK OPTION AGREEMENT Biomune Systems, Inc., a Nevada corporation (the "Company"), hereby grants this 23rd day of October, 1996, to Frank Eldredge, an individual (the "Employee"), an option to purchase a...Incentive Stock Option Agreement • December 18th, 1996 • Biomune Systems Inc • In vitro & in vivo diagnostic substances • Utah
